Allergan to Return to U.S. for Tax Purposes After AbbVie Merger

Allergan Plc will move its tax residence back to the U.S. after an earlier relocation to Dublin for tax purposes as a result of AbbVie Inc.'s $63 billion acquisition of the rival drugmaker.

AbbVie will continue to be incorporated in Delaware with its executive offices in North Chicago, Ill., the company said June 25.

• Allergan is run from New Jersey but moved its tax domicile to Dublin in 2015 through another merger, partly to take advantage of lower corporate rates abroad. The 2017 U.S. tax overhaul cut corporate levies to 21% from 35%, which reduced incentives for companies to relocate ...